Blood lead, manganese, and aluminum levels in a regional Italian cohort of ALS patients: does aluminum have an influence?
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 25285828.
- Also identified by DOI 10.1097/JOM.0000000000000266.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To study aluminum (Al), manganese (Mn), and lead (Pb) influence on amyotrophic lateral sclerosis (ALS) development. A total of 34 patients (10% of the regional ALS population) and 25 controls of an Italian region were enrolled. Metal concentrations were determined by atomic absorption spectroscopy. Serum Al concentrations in patients and controls were similar and lower than those provided by the Italian Society of Reference Values. No differences were observed in serum Mn concentrations, while, as expected, blood Pb levels were significantly higher in patients with ALS than those in controls. Results confirmed the association between high Pb blood levels and ALS; on the contrary, Al and Mn did not differ significantly in patients and controls, suggesting that Mn and especially Al may play a less important role in the ALS pathogenesis.
Medical subject headings
- Aluminum
- Amyotrophic Lateral Sclerosis
- Lead
- Manganese